Mary K Chelberg

Title: Mary K Chelberg: Innovator in Polypeptide Technology

Introduction

Mary K Chelberg is a prominent inventor based in Minneapolis, MN (US). She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that enhance cellular functions. Her work has implications for medical applications, including chemodiagnostic and chemotherapeutic devices.

Latest Patents

Mary K Chelberg holds a patent for a polypeptide with type IV collagen cell adhesion, spreading, and motility. The polypeptide is characterized by the formula: gly-val-lys-gly-asp-lys-gly-asn-pro-gly-trp-pro-gly-ala-pro. This innovative polypeptide promotes cellular adhesion and motility while remaining highly cell-specific. The potential medical applications of her invention are significant, particularly in the development of advanced diagnostic and therapeutic devices.

Career Highlights

Mary K Chelberg is affiliated with the Regents of the University of Minnesota, where she continues her research and development efforts. Her work has garnered attention for its potential to revolutionize medical treatments and improve patient outcomes.

Collaborations

Mary has collaborated with notable colleagues, including James B McCarthy and Photini-Effie C Tsilibary. These partnerships have contributed to the advancement of her research and the successful application of her inventions.

Conclusion

Mary K Chelberg is a trailblazer in the field of biotechnology, with her innovative polypeptide technology paving the way for future medical advancements. Her contributions are invaluable to the scientific community and hold promise for improving healthcare solutions.